Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancer.

ABSTRACT: About 5-10% of breast cancer cases are attributed to a gene mutation. To perform preventive interventions for women with a gene mutation, genetic screening BRCA tests have recently been implemented in Iran. The present study aimed to determine Iranian women's subjective valuation for screening BRCA tests for early detection of breast cancer to help policymakers to make decisions about genetic screening tests for breast cancer and to know the applicants. An online survey was completed by women older than 30 years old in Tehran, the capital of Iran in 2021. A hypothetical scenario about genetic screening tests for breast cancer was defined. The subjective valuation for the tests was assessed by a willingness to pay (WTP) using the contingent valuation method (CVM) by payment card. Demographi

SUBMITTER: Meshkani Z 

PROVIDER: S-EPMC10088156 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature